首页> 美国卫生研究院文献>other >A Multicenter International Survey of Renal Supportive Therapy During ECMO: The Kidney Intervention During Extracorporeal Membrane Oxygenation (KIDMO) Group
【2h】

A Multicenter International Survey of Renal Supportive Therapy During ECMO: The Kidney Intervention During Extracorporeal Membrane Oxygenation (KIDMO) Group

机译:肾支持疗法的多中心国际调查ECmO期间:肾干预在体外膜肺氧合(KIDmO)集团

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute kidney injury and fluid overload (FO) are associated with increased mortality in critically ill patients, including the subset supported with extracorporeal membrane oxygenation (ECMO). The indication for and method of application of renal support therapy (RST) during ECMO is largely unknown beyond single-center experiences. The current study uses a survey design to document practice variation regarding RST, including indication, method of interface with the ECMO circuit, and prescribing practices. Sixty-five international ECMO centers (31%) responded to an online electronic survey regarding RST during ECMO. Nearly a quarter of centers (23%) reported using no RST during ECMO. Among those using the therapy, the predominant mode of therapy applied was convection and included slow continuous ultrafiltration and continuous veno-venous hemofiltration. The predominant indication for RST was the treatment (43%) or prevention (16%) of FO. Nephrology rather than critical care medicine is reported as the prescribing service in a majority of centers with a significant difference between US centers and non-US centers. The results of this study identify a wide variation in practice regarding RST during ECMO that will offer multiple important avenues for further research by this group and others regarding the interface of RST and ECMO.
机译:急性肾脏损伤和流体过载(FO)与患者的患者的死亡率增加有关,包括用体外膜氧合(ECMO)支持的子集。 ECMO期间肾脏支持治疗(RST)施用和方法的施用和方法在很大程度上是超越单中心经验。目前的研究使用调查设计来记录关于RST的实践变化,包括指示,与ECMO电路的接口方法以及规定的实践。六十五个国际ECMO中心(31%)回应了在ECMO期间有关RST的在线电子调查。近四分之一的中心(23%)在ECMO期间使用NO RST报告。在使用治疗的那些中,所施加的主要疗法模式是对流,包括慢连续超滤和连续的静脉静脉血液过滤。 RST的主要指示是治疗(43%)或预防(16%)。肾脏学相比,肾脏病学,据报道,在大多数中心的规定服务中,美国中心和非美国中心之间具有重要差异。本研究的结果确定了ECMO期间RST的实践中的广泛变化,将提供多个重要的途径,以便通过该组和其他人提供关于RST和ECMO的界面的进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号